Dermatitis atopic and Thrombocytopenia

Summary:

Thrombocytopenia is found among people with Dermatitis atopic, especially for people who are male, 30-39 old.

The study analyzes which people have Thrombocytopenia with Dermatitis atopic. It is created by eHealthMe based on reports of 50 people who have Dermatitis atopic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

50 people who have Dermatitis Atopic and Thrombocytopenia are studied.

What is Dermatitis atopic?

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,333 drugs and 458 conditions by eHealthMe.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 4,028 drugs and 4,577 conditions by eHealthMe.

Number of Thrombocytopenia in Dermatitis atopic reports submitted per year:

Would you have Thrombocytopenia when you have Dermatitis atopic?

Gender of people who have Dermatitis Atopic and experienced Thrombocytopenia *:

female: 50 %
male: 50 %

Age of people who have Dermatitis Atopic and experienced Thrombocytopenia *:

Common co-existing conditions for these people *:

Rashes (redness): 7 people, 14.00%
Headache (pain in head): 5 people, 10.00%
Pain: 5 people, 10.00%
Nausea (feeling of having an urge to vomit): 5 people, 10.00%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 8.00%
Micturition Urgency (urgency to pass the urine): 4 people, 8.00%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 8.00%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 4 people, 8.00%
Muscle Spasms (muscle contraction): 4 people, 8.00%
Birth Control: 3 people, 6.00%

Common drugs taken by these people *:

Dupixent: 12 people, 24.00%
Cetirizine Hydrochloride: 8 people, 16.00%
Protopic: 6 people, 12.00%
Vitamin D3: 5 people, 10.00%
Oxycodone: 5 people, 10.00%
Miralax: 5 people, 10.00%
Tylenol: 5 people, 10.00%
Acetaminophen: 5 people, 10.00%
Gilenya: 4 people, 8.00%
Rocephin: 4 people, 8.00%

Common symptoms for these people *:

Headache (pain in head): 10 people, 20.00%
Fatigue (feeling of tiredness): 9 people, 18.00%
Fever: 9 people, 18.00%
Muscle Aches (muscle pain): 8 people, 16.00%
White Blood Cell Count Decreased: 7 people, 14.00%
Gait Disturbance: 7 people, 14.00%
Leukopenia (less number of white blood cells in blood): 7 people, 14.00%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 12.00%
Red Blood Cell Count Decreased: 5 people, 10.00%
Alanine Aminotransferase Increased: 5 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Thrombocytopenia?

Check whether Thrombocytopenia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

Related studies

Treatments, associated drugs and conditions:

Dermatitis atopic (74,402 reports)
Thrombocytopenia (247,406 reports)

COVID vaccines that are related to Thrombocytopenia:

Common drugs associated with Thrombocytopenia:

All the drugs that are associated with Thrombocytopenia:

Thrombocytopenia (4,028 drugs)

Common conditions associated with Thrombocytopenia:

All the conditions that are associated with Thrombocytopenia:

Thrombocytopenia (4,577 conditions)

How the study uses the data?

The study is based on Thrombocytopenia and Dermatitis atopic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.